Back to Journals » OncoTargets and Therapy » Volume 15

lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis [Retraction]

Authors Wei P, Yang J, Zhang D, Cui M, Li L

Received 19 January 2022

Accepted for publication 19 January 2022

Published 28 January 2022 Volume 2022:15 Pages 133—134

DOI https://doi.org/10.2147/OTT.S359036



Wei P, Yang J, Zhang D, Cui M, Li L. Onco Targets Ther. 2020;13:4523–4531.

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised about the reliability of the cell apoptosis data presented in the article. In addition, the total number of cancer tissue samples reported in Figures 1A, 4E and 5D was inconsistent which risked statistical deviation occurring in the results. The authors reviewed the data from their study and determined that unintentional mistakes had been made and the findings of their study were now no longer valid. The authors wish to apologise for this and asked to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.